MFDS Grants Marketing Authorization for Pfizer Korea COVID-19 Vaccine [Press Release, Mar. 5, 2021]
- Registration Date 2021-03-19
- Hit 12671
[Press Release, Mar. 5, 2021 / Unofficial Translation]
On March 5, at the Final Evaluation Committee meeting involving internal and external experts, the Ministry of Food and Drug Safety (MFDS, Minister Kim Ganglip) granted marketing authorization to Pfizer Korea for its COVID-19 vaccine, COMIRNATY Inj., on condition that the final report of the currently ongoing clinical study be submitted. The pharmaceutical company filed for marketing authorization on Jan. 25, 2021.
Division 국제협력담당관
Written by 이문선
Telephone 043-719-1597